Trials / Sponsors / Yisheng Biopharma (Singapore) Pte. Ltd.
Yisheng Biopharma (Singapore) Pte. Ltd.
Industry · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Phase I, the Study to Evaluate the Safety, Immunogenicity and Efficacy of YS-HBV-002 Chronic Hepatitis B | Phase 1 | 2024-07-01 |
| Unknown | A Study to Evaluate a PIKA Rabies Vaccine（Vero Cell）for Human Use,Freeze-dried Rabies, Prevention | Phase 3 | 2023-09-22 |
| Completed | A Phase II/III Study of PIKA Recombinant SARS-CoV-2 Vaccine as a Booster Dose. Covid-19 Vaccine | Phase 2 / Phase 3 | 2022-10-03 |
| Completed | A Phase I Study to Evaluate Safety, Tolerability, and Immunogenicity of a PIKA COVID-19 Vaccine in Healthy Ind COVID-19 Pandemic | Phase 1 | 2021-10-18 |
| Completed | Dose Escalation and Cohort Expansion Study of YS-ON-001 in Patients With Advanced Solid Tumors Cancer | Phase 1 | 2017-04-20 |
| Completed | Efficacy and Safety of a PIKA Rabies Vaccine Containing the PIKA Adjuvant With an Accelerated Regimen Rabies | Phase 2 | 2016-02-01 |
| Completed | Safety and Efficacy of a PIKA Rabies Vaccine Containing the PIKA Adjuvant Rabies | Phase 1 | 2015-02-01 |